about
Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cellsImmunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells.Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastomaNeuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.Ligand-targeted liposomal therapies of neuroblastoma.Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells.Caspase-8 gene expression in neuroblastoma.Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.Liposome-mediated therapy of neuroblastoma.In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.CHL1 gene acts as a tumor suppressor in human neuroblastoma.The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated FenretinideInduction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesionExpression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patientsExpression and methylation of CASP8 in neuroblastoma: identification of a promoter regionDNA damage or growth factor withdrawal does not evoke activation of MYB transcription factors in neuronal cancer cell linesExpression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE)
P50
Q33968452-9DB4C599-B2F3-495B-96B2-E18A3A7AFE7EQ35184976-72472283-66A2-4BAC-9240-7CE2A5F5E5AAQ35185010-FC6130C7-A840-46C1-A260-81271B0BFA7DQ35616838-1FAB6EA4-8FBD-4772-BF54-CB48EFD12DC2Q35623435-3A424F7E-837A-479A-A92B-3888BDE63AD5Q36151819-D50170DC-6489-4651-A360-C91A4A1EBDB8Q37066071-E24BB780-9345-407D-B948-99F56A78AF24Q38128317-4F79A03A-87BE-4D9E-95AE-07C3A2135497Q38315868-3535D544-5AFA-4BCD-86BC-59D2538775D7Q38868828-E7A72EBE-8A08-4EA2-BACD-8B310F2E7D19Q39882024-FF37E764-A408-4611-B870-9351F07D35D3Q39916505-C23BE5D8-F05B-41E1-BFC9-1324B8149D72Q40112525-F36B7DCB-E0F7-4E68-863C-D9B5962FF21AQ40218946-A6503BDF-1291-415A-AB14-504388B998B8Q40220978-CE773A04-827A-47BF-BF54-EAB0E4ABCE02Q40471114-62E0EB8C-0038-401E-91F4-82A37CC2BF13Q40528828-526B1798-9B8D-4B7D-BDED-8588DDB8CA01Q43117144-70B4C504-0725-4FBC-BE4C-126EC08BB662Q43242497-2EC75C8F-7E5F-4D07-8690-5EEBD91B41BFQ44321032-D061A8B2-509F-4BD9-93B3-B7BAB92C6BE9Q55039402-09F774C3-678C-4C37-9F3C-52E4B8C410D1Q55070857-04790D8D-B49F-4E24-B3CE-B44E4CC3BB38Q57980420-DDFF5E1B-A1C9-4F49-A8D2-D6D170BBCDABQ73209038-D7C788B6-7D76-432B-BD76-6631FC3E76BBQ77672309-84355D1A-E8EB-49F3-8A76-67701B404873Q78588630-BBD388CE-4364-4128-BB69-921CB0616EC7Q78727712-1D3530F6-FB4E-42E0-931B-987B806B52ADQ79268806-729E862C-0421-4B9D-AC99-48C3BC2B21D7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gabriella Pagnan
@ast
Gabriella Pagnan
@en
Gabriella Pagnan
@es
Gabriella Pagnan
@nl
type
label
Gabriella Pagnan
@ast
Gabriella Pagnan
@en
Gabriella Pagnan
@es
Gabriella Pagnan
@nl
prefLabel
Gabriella Pagnan
@ast
Gabriella Pagnan
@en
Gabriella Pagnan
@es
Gabriella Pagnan
@nl
P106
P1153
6602717768
P21
P31
P496
0000-0002-3139-8715